What We're Reading: Page 128
Industry reads hand-picked by our editors
May 09, 2022
May 06, 2022
May 05, 2022
-
Bloomberg
Cancer Drug Developers Trade Below Cash With No Respite In Sight
-
The Washington Post
Duke's Klotman is under consideration as the next NIH head
-
MarketWatch
Drug companies are making an accounting change after the SEC cracked down on Biogen
-
MIT Technology Review
The xenotransplant patient who died received a heart infected with a pig virus
May 04, 2022
May 03, 2022
May 02, 2022
Apr 29, 2022
-
The Wall Street Journal
Biotech Venture Capital Investment in China Climbs
-
BioCentury
Woodcock to remain at FDA, with focus on operations
-
The Financial Times
Moderna investors reject proposal to transfer vaccine tech
-
Politico
Califf: FDA to move 'as fast as we can' on Moderna vaccine request for kids
Previous
